Faculty profile

Richard Tytus

Back to faculty
Assistant Clinical Professor (Adjunct)Family MedicineMcMaster University

Research

Research areas, by share of publications

Research areas are derived from OpenAlex topics of their publications.

35 publications.

01

Kidney and Survival Outcomes with Semaglutide by CKD Severity in the FLOW Trial

Tuttle KR, Mann JFE, Mayrdorfer MM, Rayner B, Pugliese G, Pratley RE, Perkovic V, Mahaffey KW, Kashihara N, Jeppesen OK

American Society of Nephrology. Clinical Journal20268 citations
DOI: 10.2215/cjn.0000000974
02

Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes

Mulvagh SL, Inzucchi SE, Marx N, Poulter NR, Deanfield JE, Pop-Busui R, Emerson SS, Mann JFE, Engelmann MDM, Hovingh GK

JAMA cardiology20266 citations
DOI: 10.1001/jamacardio.2026.0245
03

A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults 18–64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8

Scott PT, Pathirana J, Kato A, Tytus R, Perez CM, Gilchrist NL, Kanou H, Yoo KH, Kania G, Nissen M

Clinical Infectious Diseases20263 citations
DOI: 10.1093/cid/ciaf604
04

Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both

Mottl A, Scott C, Green JB, Heerspink HJL, Mann JFE, McGill JB, Nangaku M, Rosenstock J, Rossing P, Li L

Journal of the American Society of Nephrology20257 citations
DOI: 10.1681/asn.0000000928
05

Impact of the COVID-19 Pandemic on Adults With Type 2 Diabetes Care and Clinical Parameters in a Primary Care Setting in Ontario, Canada: A Cross-sectional Study

Cheng AYY, Harris S, Krawchenko I, Tytus R, Hahn J, Liu A, Millson B, Golden S, Goldenberg R

Canadian Journal of Diabetes202313 citations
DOI: 10.1016/j.jcjd.2023.01.003
06

Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18–49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors

Hammitt LL, Quinn D, Janczewska E, Pasquel FJ, Tytus R, Reddy KR, Abarca K, Khaertynova IM, Dagan R, Dawson R

Human Vaccines & Immunotherapeutics20239 citations
DOI: 10.1080/21645515.2023.2177066
07

Impact of the COVID-19 Pandemic on Antihyperglycemic Prescriptions for Adults With Type 2 Diabetes in Canada: A Cross-sectional Study

Cheng AYY, Goldenberg R, Krawchenko I, Tytus R, Hahn J, Liu A, Golden S, Millson B, Harris S

Canadian Journal of Diabetes20236 citations
DOI: 10.1016/j.jcjd.2023.03.001
08

Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial

Tiwari AK, Zai CC, Altar CA, Tanner J-A, Davies PE, Traxler P, Li J, Cogan ES, Kucera MT, Gugila A

Translational Psychiatry202250 citationsOpen Access
DOI: 10.1038/s41398-022-01847-8PMID: W4220971556
09

Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18–49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY)

Hammitt LL, Quinn D, Janczewska E, Pasquel FJ, Tytus R, Reddy KR, Abarca K, Khaertynova IM, Dagan R, McCauley J

Open Forum Infectious Diseases202224 citations
DOI: 10.1093/ofid/ofab605
10

Correction: Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial

Tiwari AK, Zai CC, Altar CA, Tanner J-A, Davies PE, Traxler P, Li J, Cogan ES, Kucera MT, Gugila A

Translational Psychiatry20227 citations
DOI: 10.1038/s41398-022-01963-5

Frequent collaborators

34
Richard TytusJoseph BerlingieriMartin O'DonnellValerie TaylorAndre LamyGilmar ReisJackie BoschJohn EikelboomSalim YusufSonia AnandBenicio FreyDarryl Leong
Co-authors at McMaster University. Thicker lines mean more shared papers.Explore the network

Valerie Taylor

Psychiatry & Behavioural Neurosciences

4 shared papers, latest 2022

Joseph Berlingieri

Medicine

4 shared papers, latest 2026

Martin O'Donnell

Medicine

4 shared papers, latest 2018

Salim Yusuf

Medicine

3 shared papers, latest 2018

Jackie Bosch

Rehabilitation Science

3 shared papers, latest 2018

Sonia Anand

Medicine

3 shared papers, latest 2018

Researchers with similar interests

Jeff Nagge

Family Medicine

Blood Pressure and Hypertension Studies, Atrial Fibrillation Management and Outcomes

Robby Nieuwlaat

Health Research Methods, Evidence, and Impact

Blood Pressure and Hypertension Studies, Atrial Fibrillation Management and Outcomes

Salim Yusuf

Medicine

Blood Pressure and Hypertension Studies, Atrial Fibrillation Management and Outcomes

Hertzel Gerstein

Medicine

Diabetes Treatment and Management

Mark Loeb

Pathology & Molecular Medicine

Respiratory viral infections research, Pneumonia and Respiratory Infections

Marek Smieja

Pathology & Molecular Medicine

Pneumonia and Respiratory Infections, Respiratory viral infections research

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for
Subject: Prospective PhD student: Diabetes Treatment and Management Dear Professor Tytus, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Kidney and Survival Outcomes with Semaglutide by CKD Severity in the FLOW Trial" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]
Open in email
Something wrong or missing on this profile? Suggest a correction